- Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine.
- Use of a Modified Classic BT Shunt in a Patient With Multiple Conduit Obstructions With Positive Lupus Anticoagulant.
- A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.
- Lupus versus dermatomyositis: the hands say it all.
- Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
- Mathematical processing is affected by daily but not cumulative glucocorticoid dose in patients with systemic lupus erythematosus.
- Pentraxin 3: A promising therapeutic target for autoimmune diseases.
- Numbness and Weakness in a Patient With Systemic Lupus Erythematosus.
- SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression.
- Vogt-Koyanagi-Harada Disease and Systemic Lupus Erythematosus Occurring during Adalimumab Therapy for Ulcerative Colitis.
- Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery in Clinic.
- Transcatheter Aortic Valve Implantation in Patients with Connective Tissue Disease.
- Emerging B-Cell Therapies in Systemic Lupus Erythematosus.
- Stage one adenocarcinoma of uterine cervix in a patient with systemic lupus erythematosus – a clinical case.
- From TTP to Glomerulonephritis: A Lifetime of Lupus.
- Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide.
- Tofacitinib-induced subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis.
- Prognostic analysis of antibody typing and treatment for antiphospholipid syndrome-related recurrent spontaneous abortion.
- Remission in SLE-do DORIS criteria match the treating physician’s judgment? A cross sectional study to assess reasons for discordance.
- Algorithm for calculating high disease activity in SLE.
- Genome-wide association study on Northern Chinese identifies KLF2, DOT1L and STAB2 associated with systemic lupus erythematosus.
- Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy.
- Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2-3 mg/kg/day): 12-month prospective randomized controlled trial.
- Lupus erythematosus: Significance of dermatologic findings.
- Subacute cutaneous lupus erythematosus induced by PD-1 Inhibitor therapy: two case reports and literature review.
- Longitudinally Extensive Transverse Myelitis in a Lupus-Neuromyelitis Optica Overlap.
- Tubercular meningitis in patients with systemic lupus erythematosus: clinical characteristics, risk factors, and outcomes of 10 patients.
- Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
- Tuberculous arthritis of the ankle joint masquerading as rheumatoid arthritis in a patient with lupus nephritis.
- PREVALENCE OF THE ABCB1-1Δ GENE IN NONDOMESTIC SPECIES OF THE CANIDAE FAMILY.
- Membranous nephropathy: current understanding of various causes in light of new target antigens.
- Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets.
- Cryopreservation of Grey Wolf (Canis lupus) Testicular Tissue.
- Efficacy of Intense Pulsed Light in the Treatment of Facial Telangiectasia in Systemic Lupus Erythematosus
- Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
- Negative Pressure Wound Therapy With Instillation and Dwell Time Used to Treat Pyoderma Gangrenosum: A Case Report.
- Risk Factors for Short-Term Complication After Open Reduction and Internal Fixation of Ankle Fractures: Analysis of a Large Insurance Claims Database.
- Juvenile-onset multifocal osteonecrosis in systemic lupus erythematosus: A case report.
- Successful treatment of subdural hemorrhage and retinal hemorrhage in childhood-onset systemic lupus erythematosus associated with thrombocytopenia: Case report.
- Dihydroartemisinin attenuated the symptoms of mice model of systemic lupus erythematosus by restoring the Treg/Th17 balance.
- Mitral Valve Mass in a Patient Suspected of Systemic Lupus: Tumor, Endocarditis or Both?
- Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
- Neonatal lupus erythematosus – practical guidelines.
- Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry.
- Persistent deficiency of mucosal-associated invariant T cells during dermatomyositis.
- Young-Onset Ischemic Colitis: A Condition of Elusive Etiology Frequently Associated With Immune Dysregulation.
- Clinical characteristics of systemic lupus erythematosus with chylothorax and/or chylous ascites: An analysis of 15 cases in China.
- Subacute cutaneous lupus erythematosus in a patient with Sjögren’s syndrome taking terbinafine for onychomycosis.
- Maternal and Fetal Outcomes in Systemic Lupus Erythematosus Pregnancies.
- Refractory dermatomyositis-systemic lupus erythematosus overlap syndrome and response to tofacitinib.
- Alkaline-Encrusted Pyelitis Causing Renal Failure in a Transplant Kidney: Treatment with Percutaneous Nephrolithotomy and Urinary Acidification.
- Retrospective Analysis of the Factors Affecting Growth Parameters in Turkish Children With Systemic Lupus Erythematosus.
- Rituximab – The first twenty years.
- When POTS is the tip of the iceberg: Rare cases of dysautonomia as a possible manifestation of another disorder.
- Concomitant Diagnosis of Fibromyalgia and Ankylosing Spondylitis: Relation to Clinical Features and Plasma Pentraxin -3 Level.
- Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa.
- New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE.
- Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’.
- Clinical improvement of cardiac function in a patient with systemic lupus erythematosus and heart failure with preserved ejection fraction treated with belimumab.
- The readiness of pediatric rheumatology patients and their parents to transition to adult-oriented treatment.
- Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?
- Response to: ‘Patients with lupus are not protected from COVID-19: a comment’ by Sawalha, ‘No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit’ by Romão et al and ‘SLE patients are not immune to COVID-19: importance of sending the right message across’ by Goyal.
- MAIT cells, their biological and medical significance.
- Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum Hutch.
- The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
- Concentrated autologous bone marrow aspirate transplantation versus conservative treatment for corticosteroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.
- Lupus podocytopathy: a newly emerging nonimmune complex mediated nephropathy associated with systemic lupus erythematosus.
- Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparison.
- Cytomegalovirus in Indian systemic lupus erythematosus patients: troublemaker or onlooker?
- Limbic encephalitis in a patient with systemic lupus erythematosus successfully treated with high-dose glucocorticoids and intravenous cyclophosphamide therapy: the potential pathogenicity of anti-glutamate receptor antibodies.
- Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia.
- Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases.
- Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare.
- How a discerning cytological examination can aid in the diagnosis of infectious diseases: case reports.
- Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars
- Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
- Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus.
- Tumoral calcinosis in systemic lupus erythematosus associated with fat necrosis.
- [Clinical Features and Risk Factors of Systemic Lupus Erythematosus Complicated with Cytomegalovirus Infection].
- Childhood granulomatous periorificial dermatitis: case report and review of the literature.
- The role of Stim1 in the progression of lupus nephritis in mice.
- New findings associated with presumptive systemic lupus erythematosus in a kitten.
- Porphyria cutanea tarda exacerbation as a paraneoplastic syndrome in vaginal cancer resolved with chemoradiation.
- Prevalence of osteoporosis in patients with systemic lupus erythematosus: A multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria.
- Formulation and stability study of hydroxychloroquine sulfate oral suspensions.
- [Toxic hydroxychloroquine-induced cardiomyopathy complicating systemic lupus treatment].
- The impact of autoimmune systemic inflammation and associated medications on male reproductive health in patients with chronic rheumatological, dermatological, and gastroenterological diseases: A systematic review.
- Electron microscopy study of 496 cases of lupus nephritis: A single-center experience.
- A novel therapeutic approach using the Zipper method to treat chorea in a pediatric-onset systemic lupus erythematosus patient.
- Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK.
- How do systemic lupus erythematosus patients with very-long disease duration present? Analysis of a monocentric cohort.
- Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine.
- RITUXILUP Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
- Risk factors associated with adverse pregnancy outcomes in patients with new-onset systemic lupus erythematosus during pregnancy.
- Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.
- Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review.
- Transplantation-mediated alloimmune thrombocytopenia successfully treated by retransplantation.
- Successful treatment of severe interstitial pneumonia by removal of circulating autoantibodies: a case series.
- Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
- Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
- Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy.
- Current status of use of high throughput nucleotide sequencing in rheumatology.
- Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine.
- Inhibition of B cell activation following in vivo co-engagement of B cell antigen receptor and Fcγ receptor IIb in non-autoimmune-prone and SLE-prone mice.
- Interferon-directed therapies for the treatment of systemic lupus erythematosus: a critical update.
- COVID-19, rheumatic diseases and immune dysregulation-a perspective.
- The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases.
- Consequences of insurance denials among U.S. patients prescribed repository corticotropin injection (Acthar® Gel) for nephrotic syndrome.
- Impact of Antimalarial Adherence on Mortality among Patients with Newly Diagnosed Systemic Lupus Erythematosus: A Population-based Cohort Study.
- The complex relationship between C4b Binding Protein, warfarin and antiphospholipid antibodies.
- A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus
- Low ambient temperature increases hospital re-admissions for systemic lupus erythematosus in humid subtropical region: a time series study.
- Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus.
- A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients.
- The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.
- D-mannose ameliorates autoimmune phenotypes in mouse models of lupus.
- Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.
- Higher Hydroxychloroquine Blood Levels Are Associated with Reduced Thrombosis Risk in Systemic Lupus Erythematosus.
- A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting.
- Refractory palmo-plantar Discoid Lupus Erythematosus successfully treated with Mycophenolate Mofetil: unusual localization and literature review.
- Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus.
- Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren’s syndrome or systemic lupus erythematosus.
- Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week long therapy in patients with SLE.
- Ileocolic intussusception caused by mass-forming fibro-granulation from healed ulcer masquerading as small bowel lipoma.
- [Advances in induction therapy drugs of lupus nephritis for children].
- Generation of systemic lupus erythematosus patient-derived induced pluripotent stem cells from blood.
- Patient and parent perspectives on transition from paediatric to adult healthcare in rheumatic diseases: an interview study.
- Immune Cell-Stromal Circuitry in Lupus Photosensitivity.
- [Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up].
- Modular gene analysis reveals distinct molecular signatures for cutaneous lupus patient subsets.
- B cell depletion in murine lupus using cytotoxic T lymphocytes in vivo: Feasibility and benefit.
- B7-H3: A promising therapeutic target for autoimmune diseases.
- Anti-CD2 Antibody-Coated Nanoparticles Containing IL-2 Induce NK Cells That Protect Lupus Mice via a TGF-β-Dependent Mechanism.
- Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
- Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data.
- Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
- The Effect of Mycophenolate Mofetil as First-Line Therapy on the Timing of Urine Protein-to-Creatinine Ratio Reduction in Immunosuppressant-Naive Patients With Lupus Nephritis at a Single Center.
- Immunotherapies application in active stage of systemic lupus erythematosus in pregnancy: A case report and review of literature.
- Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus.
- Predicting lupus flares: epidemiological and disease related risk factors.
- The latest in systemic lupus erythematosus-accelerated atherosclerosis: related mechanisms inform assessment and therapy.
- Cellular aspects of the pathogenesis of lupus nephritis.
- Mobile health technologies for the management of rheumatic diseases: a systematic review of online stores in Brazil.
- COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.
- Rosai-Dorfman-Destombes Disease as First Manifestation of Systemic Lupus Erythematosus.
- Spermatic vein thrombosis with lupus anticoagulant, a cause of acute inguinal pain: a case report.
- Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant.
- Anti-neutrophil properties of natural gingerols in models of lupus.
- Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
- National Analysis of Coronary Artery Bypass Grafting in Autoimmune Connective Tissue Disease.
- Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach.
- Discovery of BIIB068: A Selective, Potent, Reversible Bruton’s Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases.
- COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration.
- A Peculiar Case of Small Bowel Stricture in a Coronavirus Disease 2019 Patient with Congenital Adhesion Band and Superior Mesenteric Vein Thrombosis.
- Innovative use of concentrated growth factors combined with corticosteroids to treat discoid lupus erythematosus alopecia: A case report.
- From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markers.
- Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review.
- Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis.
- IL-23/IL-17 axis in the pathogenesis and treatment of systemic lupus erythematosus and rheumatoid arthritis.
- Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
- Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
- Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment.
- Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment.
- Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders.
- Predictors of unsuccessful hydroxychloroquine tapering and discontinuation: Can we personalize decision-making in systemic lupus treatment?
- Beta Cell Function is Disrupted in Patients with Systemic Lupus Erythematosus.
- Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2.
- Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms.
- Evaluation of corneal safety in systemic lupus erythematosus patients undergoing long-term hydroxychloroquine treatment.
- Total Glucosides of Peony Protect Cardiomyocytes against Oxidative Stress and Inflammation by Reversing Mitochondrial Dynamics and Bioenergetics.
- Clinical Observation of COVID-19 in a Patient With an Acquired Humoral Deficiency Secondary to Chemotherapeutic Agents.
- COVID-19 in children treated with immunosuppressive medication for kidney diseases.
- Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus
- Antithyroid Drug-Induced Lupus Erythematosus and Immunoglobulin A Deficiency.
- Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform.
- Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
- Safety, Tolerability, and Pharmacokinetics of PF-06823859, an Anti-Interferon β Monoclonal Antibody: A Randomized, Phase I, Single- and Multiple-Ascending-Dose Study.
- Oxidative stress-induced aberrant lipid metabolism is an important causal factor for dysfunction of immunocytes from patients with systemic lupus erythematosus.
- Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus.
- Belimumab in lupus nephritis.
- Linear cutaneous lupus erythematosus in children-report of two cases and review of the literature: A case report.
- Understanding patient-provider discordance in adolescents with lupus: The role of pain and antidepressant medication use.
- The Effect of Biological Agents on Antinuclear Antibody Status in Patients with Psoriasis: A Single-Center Study.
- Secondary Membranous Nephropathy. A Narrative Review.
- Childhood Systemic Lupus Erythematosus; a Rare Multisystem Disorder: Case Report of a 3-year-old Girl with Oral Involvement as a Primary Sign.
- Successful hydroxychloroquine treatment in a patient with systemic lupus erythematosus-associated nailfold capillary abnormalities.
- Systemic lupus erythematosus symptom clusters and their association with patient-reported outcomes and treatment: Analysis of real-world data.
- STING-dependent induction of lipid peroxidation mediates intestinal ischemia-reperfusion injury.
- De novo lupus nephritis during treatment with belimumab.
- Bilateral ear lobe infiltration: an unusual presentation of lupus vulgaris.
- Erratum to 16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends.
- Liquid Chromatographic Methods for COVID-19 Drugs, Hydroxychloroquine and Chloroquine.
- Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double-blind Phase Ib study.
- Basophils and IgE contribute to Mixed Connective Tissue Disease development.
- Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases.
- CD95/Fas and metastatic disease: What does not kill you makes you stronger.
- Kikuchi-Fujimoto disease preceded by lupus erythematosus panniculitis: do these findings together herald the onset of systemic lupus erythematosus?
- CD74 auto-antibodies display little clinical value in Chinese Han population with axial spondyloarthritis.
- Glomerular Disease and Pregnancy.
- Discovery of M5049: A Novel Selective TLR7/8 Inhibitor for Treatment of Autoimmunity.
- VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism.
- Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function.
- Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells.
- IL-Y Aggravates Murine Chronic Graft-Versus-Host Disease by Enhancing T and B Cell Responses.
- New therapeutic approaches in systemic lupus erythematosus.
- B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE).
- Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
- MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.
- Xanthogranulomatous pleuritis – An unusual presentation of tuberculosis.
- Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
- Cryptococcemia According to Immune Status: An Analysis of 65 Critical Cases.
- Hepatocellular adenoma(s) arising in nodular regenerative hyperplasia in a patient with systemic lupus erythematosus.
- Coxiella burnetii Endocarditis in a Patient with Systemic Lupus Erythematosus: A Case Report of a Diagnostic Challenge.
- Neutrophil Activation and Neutrophil Extracellular Trap Formation in Dialysis Patients.
- Comparison of effectiveness of topical Tacrolimus 0.1% vs topical Halobetasol Propionate 0.05% as an add-on to oral Hydroxychloroquine in Discoid Lupus Erythematosus.
- The place of sphingosine-1-phosphate modulators in the therapy of inflammatory bowel diseases
- Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: a Danish nationwide cohort study.
- Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
- Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study.
- Effects and interferences of emicizumab, a humanized bispecific antibody mimicking activated factor VIII cofactor function, on lupus anticoagulant assays.
- Therapeutic effects of soluble human leukocyte antigen G2 isoform in lupus-prone MRL/lpr mice.
- Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014.
- Primary Sjögren’s Syndrome and Cardiovascular Disease.
- Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
- Application of the 2019 European League Against Rheumatism/American College of Rheumatology systemic lupus erythematosus classification criteria in clinical practice: a single center experience.
- Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden.
- What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
- Extraction of DNA from plastinated tissues.
- Elective Termination of Pregnancy in Autoimmune Rheumatic Diseases: Experience From Two Databases.
- Peripheral B Cell Subsets in Autoimmune Diseases: Clinical Implications and Effects of B Cell-Targeted Therapies.
- Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases.
- Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay.
- Lupus nephritis-related issues during COVID-19 pandemic quarantine.
- Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A1 in patients with lupus nephritis.
- Tocilizumab and its usage for skin diseases.
- Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries.
- Lung Cancer Survival in Patients With Autoimmune Disease.
- Reduction in SLEDAI is associated with improved arterial stiffness in systemic lupus erythematosus.
- CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritis.
- Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: A population-based cohort study.
- Improving eye screening practice among pediatric rheumatology patients receiving hydroxychloroquine.
- Systemic lupus erythematosus-related acute pancreatitis.
- Systemic lupus erythematosus: The search for the ideal biomarker.
- Advances in Microbiome Detection Technologies and Application in Antirheumatic Drug Design.
- Genetic variant CFH rs6677604 might play a protective role in lupus nephritis.
- Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL).
- Simultaneous Presentation of Parvovirus B19 Infection and Systemic Lupus Erythematosus in a Patient: Description and Review of the Literature.
- Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study.
- A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.
- The role of neuraminidase in TLR4-MAPK signaling and the release of cytokines by lupus serum-stimulated mesangial cells.
- Myocardial Infarction in Systemic Lupus Erythematosus – the Sex Specific Risk Profile.
- Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice.
- Systemic erythematous lupus after treatment of multiple sclerosis with alemtuzumab.
- Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.
- Non-infective supraglottitis: two cases of unusual aetiology.
- Ovarian antibodies among SLE women with premature menopause after cyclophosphamide.
- Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis.
- A glance upon Epigenetic and COVID-19.
- Cutaneous Kikuchi disease-like inflammatory pattern without lymph node involvement is associated with systemic disease and severe features in lupus erythematous: A case-control study.
- BTK inhibition modulates multiple immune cell populations involved in the pathogenesis of immune mediated nephritis.
- Clinical Review Report: Belimumab (Benlysta): (GlaxoSmithKline Inc.): Indication: Indicated in addition to standard therapy for reducing disease activity in adult patients with active, autoantibody-positive systemic lupus erythematosus
- Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus.
- Common causes of hair loss – clinical manifestations, trichoscopy and therapy.
- Regulatory effect of glutathione on treg/Th17 cell balance in allergic rhinitis patients through inhibiting intracellular autophagy.
- Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs.
- Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors.
- The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?
- Treatment targets in SLE: remission and low disease activity state.
- The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?
- Treatment of severe thrombocytopenia associated with systemic lupus erythematosus in pregnancy with eltrombopag: A case report and literature review.
- Long-term remission in patients with systemic lupus erythematosus.
- The Type II anti-CD20 Antibody Obinutuzumab (GA101) is More Effective than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model.
- Intestinal Pseudo-Obstruction as the Initial Clinical Presentation in Systemic Lupus Erythematosus: A Rare and Severe Disorder.
- Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome.
- Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs).
- Successful treatment by mycophenolate mofetil of subacute progressive interstitial lung disease associated with systemic lupus erythematosus.
- A woman with systemic lupus erythematosus, multiple pregnancy complications, and cerebral infarction who was only positive for phosphatidylserine-dependent antiprothrombin antibodies.
- Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.
- Evans’ Syndrome: From Diagnosis to Treatment.
- What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
- IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.
- Sodium Butyrate Ameliorates Gut Microbiota Dysbiosis in Lupus-Like Mice.
- Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing.
- Platelet proteome changes in dogs with congestive heart failure.
- IgA autoantibodies directed against self DNA are elevated in cystic fibrosis and associated with more severe lung dysfunction.
- Factors Associated with Rapid Progression to End Stage Kidney Disease in Lupus Nephritis.
- Tuberculosis in patients with systemic lupus erythematosus: a 37-year longitudinal survey-based study.
- Clinical features and outcomes from the Singapore Sjögren’s syndrome study.
- Study of M5049 in Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) Participants
- Low-dose 17α-ethinyl estradiol (EE) exposure exacerbates lupus renal disease and modulates immune responses to TLR7/9 agonists in genetically autoimmune-prone mice.
- Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells.
- A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
- New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre.
- Bach2 overexpression represses Th9 cell differentiation by suppressing IRF4 expression in systemic lupus erythematosus.
- Diffuse Alveolar Haemorrhage in Systemic Lupus Erythematosus Patients.
- Association of Traditional Chinese Medicine Use With Adherence to Prescribed Western Rheumatic Medications Among Chinese American Patients: A Cross-Sectional Survey.
- Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus.
- Response to: ‘Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian et al’ by Notz et al.
- Gut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupus.
- Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy.
- BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid.
- Necrotizing lymphadenitis : A case report and literature review.
- Pharmacoeconomic Review Report: Belimumab (Benlysta): (GlaxoSmithKline Inc.): Indication: Indicated in addition to standard therapy for reducing disease activity in adult patients with active, autoantibody-positive systemic lupus erythematosus
- Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia.
- Protein A immunoadsorption combination with immunosuppressive therapy improves neuropsychiatric systemic lupus erythematosus: A case report.
- Q-fever prosthetic valve endocarditis in a patient with SLE and antiphospholipid antibody syndrome.
- Employing a latent variable framework to improve efficiency in composite endpoint analysis.
- Retinal and choroidal thickness changes in systemic lupus erythematosus patients: a longitudinal study.
- Systemic lupus erythematosus, antiphospholipid syndrome and Hashimoto thyroiditis occurring in a patient with Niemann-Pick disease: a second case.
- Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study.
- Combining miR-23b exposure with mesenchymal stem cell transplantation enhances therapeutic effects on EAE.
- Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
- Suppression of systemic lupus erythematosus in NZBWF1 mice infected with Hymenolepis microstoma.
- Investigating lupus retention in care to inform interventions for disparities reduction: an observational cohort study.
- Systemic lupus erythematosus gastrointestinal involvement: a computed tomography-based assessment.
- Lupus Nephritis and Chronic Kidney Disease.
- Learning to listen: how empathetic engagement with patients can help overcome reproductive injustice.
- A Study to Assess the Safety and Tolerability, PK and Efficacy of KPG-818 in Mild to Moderate SLE Patients
- Anti-tumor necrosis factor (TNF)-induced lupus in a patient with hidradenitis suppurativa.
- Case Series of Chronic Inflammatory Rheumatic Disease Patients Infected by Coronavirus Disease 2019 (COVID-19).
- Clinical Outcomes of Hip Arthroscopy in Patients With Systemic Inflammatory Diseases Compared With Matched Controls at a Minimum of 2-Year Follow-Up.
- Severe mitral valve regurgitation secondary to Libman-Sacks endocarditis.
- A case of acute myelogenous leukemia characterized by arterial and venous thrombosis.
- Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus.
- Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
- Lupus Anticoagulant in Patients with Covid-19. Reply.
- Long-term safety and efficacy of anifrolumab in adults with systemic lupus erythematosus: results of a phase 2 open-label extension study.
- A Comparison Of Mycophenolate Mofetil And Cyclophosphamide As Lupus Nephritis Induction Therapy.
- Impact of systemic factors in shaping the periodontal microbiome.
- NCS 613, a PDE4 inhibitor, by increasing cAMP level suppresses systemic inflammation and immune complexes deposition in kidney of MRL/lpr lupus- prone mice.
- Belimumab in Lupus Nephritis: New Trial Results Arrive During an Exciting Time for Therapeutics.
- Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: a multicenter retrospective observational study of 40 patients.
- Fracture risk in systemic lupus erythematosus patients over 28 years.
- Hemolytic Disease of the Fetus and Newborn Caused by Maternal Autoantibody with Mimicking Anti-E Specificity.
- Plaque-like Cutaneous Lupus Mucinosis as the First Sign of Systemic Lupus Erythematosus.
- Towards a practical management of fatigue in systemic lupus erythematosus.
- Anifrolumab for the treatment of active systemic lupus erythematosus: a meta-analysis of randomized controlled trials.
- The use of anti-TNF-alpha therapies for patients with Systemic Lupus Erythematosus. Where are we now?
- Pulmonary hypertension in connective tissue diseases, new evidence and challenges.
- Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: Systematic Literature Review by the Lupus Task Force of the OMERACT Ultrasound Working Group.
- An Elusive Case of Mycosis Fungoides: Case Report and Review of the Literature.
- Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.
- Isoradiotopic response of discoid lupus after radiotherapy: A case report and review of the literature.
- Cryptococcal meningitis in patients with lupus nephritis.
- Neutrophil Extracellular Traps in Autoimmunity and Allergy: Immune Complexes at Work.
- Systemic lupus erythematosus in the setting of HIV-1 infection: a longitudinal analysis.
- Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus.
- The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock.
- Multi-pronged approach to enhance education of children and adolescents with lupus, caregivers, and healthcare providers in New Jersey: Needs assessment, evaluation, and development of educational materials.
- [AN UNUSUAL DIAGNOSIS OF CHRONIC URTICARIA].
- Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.
- Atrial thrombus as a complication of SLE and APS in an 8-year-old child.
- Systemic Lupus Erythematosus, Its Impact on Selected Cardiovascular Risk Factors, and Correlation with Duration of Illness: A Pilot Study.
- A Case of Prolonged Catatonia Caused by Sjögren’s Syndrome.
- Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®.
- Calcified constrictive pericarditis resulting in tamponade in a patient with systemic lupus erythematosus.
- Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies.
- Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide.
- Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis.
- [Pyoderma gangrenosum and systemic lupus erythematosus: A rare association].
- Systemic Lupus Erythematosus.
- Pulmonary hypertension associated with congenital heart block and neonatal lupus syndrome: A series of four cases.
- Relationship between disease activity, organ damage and health-related quality of life in patients with systemic lupus erythematosus: A systemic review and meta-analysis.
- Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus.
- Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic.
- Time-Dependent Changes in Porcelain Aorta and Aortic Stenosis in a Patient with Systemic Lupus Erythematosus.
- A case report of hydroxychloroquine-induced auditory and visual hallucination.
- Successful Treatment of Urticarial Vasculitis in a Patient With Systemic Lupus Erythematosus With Rituximab.
- Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry.
- Autoimmunity in Segmental Vitiligo.
- COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics.
- Fractalkine mediates lymphocyte inflammation and tubulointerstitial lesions by modifying the Treg/Th17 balance in lupus-prone MRL/lpr mice.
- Rare Association of Antiphospholipid Antibody Syndrome, Systemic Lupus Erythematosus and Aortic Dissection: A Striking Presentation with Multi-Organ Failure?
- Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies.
- Early Treatment of Interleukin-33 can Attenuate Lupus Development in Young NZB/W F1 Mice.
- Application of procalcitonin, white blood cell count and neutrophil-to-lymphocyte ratio in the diagnosis of systemic lupus erythematosus with a bacterial infection.
- Experimental Study of Nanostructured Lipid Carrier in the Treatment of Immune Lupus Nephritis.
- Effects of Nano-α-Linolenic Acid and miR-146 on Mice with Viral Myocarditis.
- B-cell depletion or belimumab or voclosporin for lupus nephritis?
- A Proposed Aeromedical Disposition Flowchart for Systemic Lupus Erythematosus.
- Associations of metabolic syndrome in SLE.
- Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research.
- Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.
- Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.
- Prevalence and associated factors of medication nonadherence among Thai patients with systemic lupus erythematosus.
- Serum and Urine Monocyte Chemoattractant Protein-1 as A Markers for Lupus Nephritis.
- Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring.
- Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
- Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
- Corticosteroid associated lupus pancreatitis.
- Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice.
- Extracellular Chromatin Triggers Release of Soluble CEACAM8 Upon Activation of Neutrophils.
- Outcome and Prognosis of Patients With Lupus Nephritis Submitted to Renal Transplantation.
- Galectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristane.
- Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond.
- Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa.
- Transplant outcomes in kidney recipients with lupus nephritis, and systematic review.
- Systemic lupus erythematosus aggravates atherosclerosis by promoting IgG deposition and inflammatory cell imbalance.
- Systemic lupus erythematosus with autoimmune neurological manifestations in a carrier of chronic granulomatous disease – a rare presentation.
- Acquired hemophilia A in a woman with systemic lupus erythematosus: A case report and review of literature.
- Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
- Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells.
- Emerging Technologies to Target Drug Delivery to the Skin – the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone.
- Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.
- “Coronavirus could kill me #StayHomeSaveLives”: A content and sentiment analysis of tweets by people with arthritis during COVID-19.
- Acute parkinsonism in patients with systemic lupus erythematosus: A case report and review of the literature.
- Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort.
- Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports.
- Dorsolateral medullary infarction during skin infection by Stenotrophomonas maltophilia in a patient with triple antiphospholipid antibody positivity: a case-based review.
- Neuronal surface P antigen (NSPA) modulates postsynaptic NMDAR stability through ubiquitination of tyrosine phosphatase PTPMEG.
- Neurosurgical and neuro-immunological management of IgG4-related hypertrophic sclerosing pachymeningitis. A literature survey and discussion of a unique index case.
- Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review.
- Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family.
- Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report.
- Efficacy and safety of rituximab for systemic lupus erythematosus treatment: a meta-analysis.
- Side Effects of Chloroquine and Hydroxychloroquine on Skeletal Muscle: a Narrative Review.
- Age-Associated B Cells (ABCs) in the Prognosis, Diagnosis and Therapy of Systemic Lupus Erythematosus (SLE).
- A Rare Case with Systemic Lupus Erythematosus Manifested by two Different Neurologic Entities; Guillain Barre Syndrome and Posterior Reversible Encephalopathy Syndrome.
- Thromboendarterectomy in a patient with Systemic Lupus and antiphospholipid Syndrome, lessons learned from a complex disease interaction.
- COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.
- Refractory Urticaria with Raised Antistreptolysin O (ASO) Titer: An Intriguing Case of Adult-Onset Still’s Disease.
- Rheumatologists’ perspective on hydroxychloroquine guidelines.
- Prediction of hospitalizations in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI).
- The HSP90 Inhibitor, 17-AAG, Influences the Activation and Proliferation of T Lymphocytes via AKT/GSK3β Signaling in MRL/lpr Mice.
- Concomitant onset of systemic lupus erythematosus and disseminated histoplasmosis: a case-based review.
- Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.
- Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
- Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
- An unusual case of acute lower gastrointestinal bleeding due to fungal infection.
- A Case of Systemic Lupus Erythematosus with Malignant Pleural Mesothelioma in a 42-year Woman.
- Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial.
- Diffuse alveolar hemorrhage, a rare presentation of polymyositis.
- Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug.
- Complement C4A Regulates Autoreactive B Cells in Murine Lupus.
- Update on Lupus Nephritis: Looking for a New Vision.
- Lupus-like Disease in FcγRIIB-/- Mice Induces Osteopenia.
- [Secondary ITP in adults].
- [Cytomegalovirus infection in systemic lupus erythematosus patients. A series of 12 case reports and literature review].
- Efficacy and safety of rituximab biosimilar in refractory lupus.
- Belimumab in the treatment of Portuguese Systemic Lupus Erythematosus patients: a real-life multicenter study.
- Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis.
- Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus: a case-based review.
- Twelve-Week Internet-Based Individualized Exercise Program in Adults With Systemic Lupus Erythematosus: Protocol for a Randomized Controlled Trial.
- Lupus myocarditis in an octogenarian patient-a case report.
- Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa.
- Parvovirus B19 infection mimicking systemic lupus erythematosus, successfully treated with intravenous immune globulin.
- Targeted delivery of immunosuppressant in SLE.
- [The place of riociguat in the treatment of patients with pulmonary arterial hypertension associated with systemic connective tissue diseases].
- Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis.
- Anti-Müllerian hormone in African-American women with systemic lupus erythematosus.
- Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients.
- Intrarenal injection of mesenchymal stem cell for treatment of lupus nephritis in mice – a pilot study.
- Endothelial dysfunction and cardiovascular risk in lupus nephritis: new roles for old players?
- Cucurbitacin IIb improved active chromatin-induced systemic lupus erythematosus via balancing the percentage of Th17 and Treg cells.
- Lymphocyte subset clustering analysis in treatment-naive patients with systemic lupus erythematosus.
- Silica Exposure Differentially Modulates Autoimmunity in Lupus Strains and Autoantibody Transgenic Mice.
- Nephritic Syndrome.
- Association of AIRE (rs2075876), but not CTLA4 (rs231775) polymorphisms with Systemic Lupus Erythematosus.
- TNIP1/ABIN1 and lupus nephritis: review.
- Emicizumab-Induced Seronegative Full-House Lupus Nephritis in a Child.
- Talaromyces marneffei Infection in Systemic Lupus Erythematosus Patients: Report of Two Cases and Review of the Literature.
- Omega-3 Docosahexaenoic Acid (DHA) Impedes Silica-Induced Macrophage Corpse Accumulation by Attenuating Cell Death and Potentiating Efferocytosis.
- A Comprehensive Review of Biological Agents for Lupus: Beyond Single Target.
- Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis.
- Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.
- Lupus and NMOSD: The Blending of Humoral Autoimmunity.
- Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren’s Syndrome.
- The association between active proliferative lupus nephritis during pregnancy and small for gestational age newborns.
- Uric acid as a risk factor for progression to chronic kidney disease in patients with lupus nephritis: results from the KORNET registry.
- The gut microbiota of non-treated patients with SLE defines an autoimmunogenic and proinflammatory profile.
- A Novel Network Pharmacology Strategy to Decode Mechanism of Lang Chuang Wan in Treating Systemic Lupus Erythematosus.
- Milk fat globule epidermal growth factor 8 (MFG-E8) on monocytes is a novel biomarker of disease activity in systemic lupus erythematosus.
- Predictors of the start of declining eGFR in patients with systemic lupus erythematosus.
- Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study.
- Discovery of Small Molecule Drugs Targeting the Biogenesis of microRNA-155 for the Treatment of Systemic Lupus Erythematosus.
- Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
- Acute Kidney Injury Caused by Evans Syndrome with Systemic Lupus Erythematosus and Systemic Sclerosis.
- Autoimmune Hypophysitis With Systemic Lupus Erythematosus: A Case Report and Literature Review.
- SLE: Novel Postulates for Therapeutic Options.
- T Cells in Autoimmunity-Associated Cardiovascular Diseases.
- Application of LC-MS/MS method for determination of dihydroartemisin in human plasma in a pharmacokinetic study.
- Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study.
- Atherosclerotic plaque vulnerability is increased in mouse model of lupus.
- Clinical profile of osteonecrosis in systemic lupus erythematosus – Experience from a tertiary care centre in South India.
- Assessing outcomes in a lupus nephritis cohort over a 40-year period.
- Successful treatment of erythematous-squamous disorders of the external auditory canal with tacrolimus and clotrimazole in otic oil: our experience in 25 patients.
- Treating Systemic Lupus Erythematosus (SLE): The Impact of Historical Environmental Context on Healthcare Perceptions and Decision-Making in Charleston, South Carolina.
- Taxing the brain: a case of neuropsychiatric systemic lupus erythematosus.
- Multifactorial aggressive and reversible cardiomyopathy in systemic lupus erythematosus.
- Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population.
- Lupus-like nephritis with positive anti-neutrophil cytoplasmic antibodies and negative antinuclear antibodies.
- The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients.
- Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus.
- Associated clinical factors for serious infections in patients with systemic lupus erythematosus.
- Hyaluronic Acid Synthesis Contributes to Tissue Damage in Systemic Lupus Erythematosus.
- Trends of Hospital Palliative Care Utilization and Its Associated Factors Among Patients With Systemic Lupus Erythematosus in the United States From 2005 to 2014.
- Dialysis in Pregnancy: Role of the Underlying Cause of Renal Failure on Peripartum Outcomes.
- Digital Therapeutic Platform for Management of Systemic Lupus Erythematosus.
- 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
- Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model.
- Lupus Vulgaris and Lichen Scrofulosorum with Disseminated Tuberculosis.
- Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus.
- Trabecular Bone Score and Bone Quality in Systemic Lupus Erythematosus Patients.
- Bronchiolitis obliterans organizing pneumonia as the pulmonary manifestation of lupus: A review of three cases.
- Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus: reply.
- The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation.
- A case of γδ T-cell large granular lymphocytic leukemia due to a chronic active Epstein-Barr virus infection in systemic lupus erythematosus.
- Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLE.
- Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations.
- In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus.
- Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials.
- Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease.
- Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases.
- Renal Infiltration as a Primary Presentation of Burkitt Lymphoma Secondary to Systemic Lupus Erythematosus: A Rarity Unto a Rarity.
- Case study of tacrolimus as an effective treatment for idiopathic membranous glomerulonephritis in pregnancy.
- What about glucocorticoids in primary Sjögren’s syndrome?
- A case of systemic sclerosis/lupus overlap syndrome presenting with bilateral cotton wool spots.
- Recurrent Stevens-Johnson syndrome in a patient with systemic lupus erythematosus: a case report.
- A case of systemic lupus erythematosus in which Cushing’s syndrome caused by adrenal adenoma accidentally occurred during long-term maintenance therapy with corticosteroids.
- Atypical femoral fracture associated with delayed union for which the cessation of alendronate and daily administration of teriparatide contributed to fracture healing: histopathological evidence of the enhancement in bone formation parameters.
- Autoimmune myelofibrosis associated with systemic lupus erythematosus: a case report.
- Concurrent onset of acute lupus myocarditis, pulmonary arterial hypertension and digital gangrene in a lupus patient: a possible role of vasculitis to the rare disorders.
- Treatment of psoriatic arthritis complicated by systemic lupus erythematosus with the IL-17 blocker secukinumab and an analysis of the serum cytokine profile.
- Clinical presentation of a neuropsychiatric lupus patient with symmetrical basal ganglia lesions containing cytotoxic oedema cores surrounded by vasogenic oedema.
- Multifocal osteoarticular tuberculosis in a systemic lupus erythematosus (SLE) patient: a rarity or an underdiagnosed condition?
- Successful treatment of refractory acute lupus haemophagocytic syndrome using rituximab: a case report.
- Systemic lupus erythematosus with repeated protein-losing enteropathy resulting from different pathological conditions: a case report.
- Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
- The Investigation of the Association of Cutaneous Leishmaniasis in Biopsy Specimens of the Patients with Granulomatous Disease and Skin Cancer Using the Molecular Method.
- Value of Urinary Neutrophil Gelatinase-Associated Lipocalin versus Conventional Biomarkers in Predicting Response to Treatment of Active Lupus Nephritis.
- STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation.
- Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice.
- A case of chronic sarcoidosis presenting with lupus pernio.
- Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
- Next stop in the treatment of refractory systemic lupus erythematosus: B-cell targeted combined therapy.
- Pediatric catastrophic antiphospholipid syndrome patient evolving to systemic lupus erythematosus.
- Candidate drug replacements for quinacrine in cutaneous lupus erythematosus.
- Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis.
- Diagnoses, Outcomes, and Chronicity Predictors of Patients with Secondary Immune Thrombocytopenia: Ten-Year Data from a Hematology Referral Center.
- Pharmacokinetics and Pharmacodynamics of JNJ-55920839, an Antibody Targeting Interferon α/ω, in Healthy Subjects and Subjects with Mild-to-Moderate Systemic Lupus Erythematosus.
- Anti-IFNαR Mabs for the treatment of Systemic Lupus Erythematosus.
- The TLC-NOSF (Technology Lipido-Colloid Plus Nano-Oligo Saccharide Factor) protease inhibitor for the treatment of ulceration in rheumatic disease A case report.
- MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway.
- Complement Inhibitors in Clinical Trials for Glomerular Diseases.
- Antiphospholipid syndrome and infertility.
- Choroidal thickness in lupus nephritis.
- Septicaemia is associated with increased disease activity and mortality in systemic lupus erythematosus: a retrospective analysis from Taiwan.
- COVID-19 in a patient with a flare of systemic lupus erythematosus: a rare case-report.
- Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus Derived from a Digital Therapeutic Plus Tele-Health Coaching Intervention: Randomized Controlled Pilot Trial.
- IL-38: A novel cytokine in systemic lupus erythematosus pathogenesis.
- Mortality in patients with systemic lupus erythematosus and neuropsychiatric involvement: A retrospective analysis from a tertiary referral center in the Netherlands.
- Psychotherapy for the Treatment of Acute Musculoskeletal Pain: A Review of Clinical Effectiveness and Guidelines
- Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians.
- The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis.
- Sustained Remission of Lupus Panniculitis Treated With Hydroxychloroquine in a Patient With Crohn’s Disease: A Case Report.
- Pathological RANK signaling in B cells drives autoimmunity and chronic lymphocytic leukemia.
- Antiphospholipid syndrome.
- Update οn the diagnosis and management of systemic lupus erythematosus.
- Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal study.
- Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus.
- Kidney transplantation in systemic lupus erythematosus: Outcomes and prognosis.
- EULAR recommendations for a core data set for pregnancy registries in rheumatology.
- Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials.
- Clinical management of Lupus patients during the COVID-19 pandemic.
- Radiotherapy for Cervical Cancer in Patients with Systemic Lupus Erythematosus.
- Development and exacerbation of pulmonary nontuberculous mycobacterial infection in patients with systemic autoimmune rheumatic diseases.
- Complement Activation on Endothelial Cell-Derived Microparticles-A Key Determinant for Cardiovascular Risk in Patients with Systemic Lupus Erythematosus?
- Clinical characteristics and prognosis of concomitant systemic lupus erythematosus and primary biliary cholangitis.
- A simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus.
- Pilocarpine for Sjögren’s Syndrome-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
- Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation.
- A Histologic Analysis of a Retrieved Specimen 24 Years after Hemiresurfacing for Avascular Necrosis.
- Serum adiponectin levels are associated with presence of carotid plaque in women with systemic lupus erythematosus.
- Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies.
- Peculiar blood flow profiles among placental chorionic villous vessels of an abnormally thick placenta in a case of systemic lupus erythematosus characterized using microvascular imaging.
- Early damage as measured by SLICC/ACR damage index is a predictor of hospitalization in systemic lupus erythematosus (SLE).
- Natural history of nonbacterial thrombotic endocarditis treated with warfarin.
- The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis.
- Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
- Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr mice.
- Central Nervous System Vasculitis Secondary to Sarcoidosis: A Rare Case of Lupus Pernio With Complete Occlusion of Right Internal Carotid Artery.
- Spectrum of autoimmune bullous diseases among children in Kuwait.
- Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis.
- Tumor necrosis factor inhibitor-induced pleuropericarditis: A retrospective evaluation using data from VigiBase.
- Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocytes-mediated Bullous Skin Disorders.
- Upregulation of FoxO3a expression through PI3K/Akt pathway attenuates the progression of lupus nephritis in MRL/lpr mice.
- Coronary Artery Bypass Grafting in Patients with Systemic Lupus Erythematosus.
- Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing.
- Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways.
- Src Family Protein Kinase Controls the Fate of B Cells in Autoimmune Diseases.
- Systemic lupus erythematosus (SLE): emerging therapeutic targets.
- Unexpectedly, low hydroxychloroquine concentration enhances DNA-induced immune stimulation in vitro: potential implication in non-compliant patients with SLE.
- Methotrexate-induced toxic epidermal necrolysis in a child undergoing a combination therapy for systemic lupus erythematosus: a rare case report.
- Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus
- Causes, Risk Factors, and Clinical Outcomes of Stroke in Korean Young Adults: Systemic Lupus Erythematosus is Associated with Unfavorable Outcomes.
- Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
- A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum.
- Correspondence on ‘Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis’.
- Response to: ‘Correspondence on ‘Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis” by Xu.
- 24-hour Activity and Sleep Profiles for Adults Living with Arthritis: Habits Matter.
- Comorbidity and health care utilisation in persons with Sjögren’s syndrome: a claims data analysis.
- Increasing Ancestral Diversity in Systemic Lupus Erythematosus Clinical Studies.
- Thrombophilia testing in patients with portal vein thrombosis.
- No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?
- Chinese herbal compound prescription for systemic lupus erythematosus: A protocol for systematic review and meta-analysis.
- A BAYESIAN ADAPTIVE TWO-STAGE DESIGN FOR PEDIATRIC CLINICAL TRIALS.
- Refractory liver dysfunction was remarkably improved with chelating agents of Wilson’s disease, in a patient with systemic lupus erythematosus-like syndrome after a parvovirus B19 infection.
- Factors Related to Knowledge, Perception, and Practices Towards COVID-19 Among Patients with Autoimmune Diseases: A Multicenter Online Survey.
- Neuropsychiatric systemic lupus erythematosus with cerebellar vasculitis and obstructive hydrocephalus requiring decompressive craniectomy.
- Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.
- Development of Chronic Cutaneous Lupus Erythematosus During Biologic Therapy: A Systematic Review.
- Lupus Low Disease Activity State and Reduced Direct Health Care Costs in Patients With Systemic Lupus Erythematosus.
- Salmonella enterica Subspecies arizonae Detected from Bilateral Pleural Fluid in a Patient with Systemic Lupus Erythematosus and Malignant Lymphoma.
- Cytomegalovirus-induced cutaneous ulcer mimicking vasculitis in a patient with systemic lupus erythematous: A case report and review of the literature.
- Clinical Characteristics, Management Practices, and In-hospital Outcomes among Trauma Patients with Venous Thromboembolism.
- B Cell Subsets and Cellular Signatures and Disease Relapse in Lupus Nephritis.
- Fecal Metabolites Were Altered, Identified as Biomarkers and Correlated With Disease Activity in Patients With Systemic Lupus Erythematosus in a GC-MS-Based Metabolomics Study.
- Mesenchymal stem cells prevent overwhelming inflammation and reduce infection severity via recruiting CXCR3+ regulatory T cells.
- A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature.
- Prevalence of antimitochondrial antibodies in subacute cutaneous lupus erythematosus.
- Dermatologic Applications and Safety Considerations of Janus Kinase Inhibitors.
- Airways therapy of obstructive sleep apnea dramatically improves aberrant levels of soluble cytokines involved in autoimmune disease.
- [Immune disorders associated with juvenile recurrent chronic parotitis].
- Response to ustekinumab treatment in patients with systemic lupus erythematosus is linked to suppression of serum interferon gamma levels.
- Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment.
- Innate immune response in systemic autoimmune diseases: a potential target of therapy.
- The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus.
- Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a “humanized” G6PD A- mouse model.
- Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.
- Bone marrow transplantation from a human leukocyte antigen-mismatched unrelated donor in a case with C1q deficiency associated with refractory systemic lupus erythematosus.
- PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis.
- Biologics in the treatment of Sjogren’s syndrome, systemic lupus erythematosus, and lupus nephritis.
- Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient: From the National Multiple Sclerosis Society Case Conference Proceedings.
- Proteomic Analyses of Endarterectomized Tissues from Patients with Chronic Thromboembolic Pulmonary Hypertension.
- Ovoid palatal patch: a clue to anti-TIF1γ dermatomyositis.
- Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
- Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients.
- Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
- Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models.
- Secondary angle-closure glaucoma as an ocular presentation of systemic lupus erythematosus: a case report.
- Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus.
- The effect of parity, history of preeclampsia, and pregnancy care on the incidence of subsequent preeclampsia in multiparous women with SLE.
- Knowledge and attitudes about influenza vaccination in rheumatic diseases patients.
- Cardiac Manifestations of Systemic Lupus Erythematous: An Overview of the Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology and Treatment Options.
- Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.
- Dexamethasone Prodrug Nanomedicine (ZSJ-0228) Treatment Significantly Reduces Lupus Nephritis in Mice without Measurable Side Effects – A 5-Month Study.
- Increasing Ancestral Diversity in Lupus Trials: Ways Forward.
- Successful treatment of HIV-associated lupus-like glomerulonephritis with mycophenolic acid.
- Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study.
- Prevalence, predictors and prognostic benefits of remission achievement in patients with systemic lupus erythematosus: a systematic review.
- Complication of Mycobacterium tuberculosis treatment: Isoniazid-induced pneumonitis.
- Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia.
- The role of TASL in the pathogenesis of SLE: X marks the spot.
- SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
- The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.
- Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis.
- Gilbert syndrome with systemic lupus erythematosus presenting with persistent unconjugated hyperbilirubinemia: A case report.
- Cellulitis with Pseudomonas putida bacteremia in a patient with systemic lupus erythematosus: A case report.
- Predictive factors of the lupus nephritis in a Tunisian cohort.
- High prevalence of acquired thrombophilia without prognosis value in Covid-19 patients.
- Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
- A case of eosinophilic fasciitis without skin manifestations: a case report in a patient with lupus and literature review.
- Analysis of time course and dose effect of tacrolimus on proteinuria in lupus nephritis patients.
- Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances.
- Response to: “A combination of complement activation products with autoantibodies predicts transition of probable lupus to systemic lupus erythematosus”.
- Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay.
- Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
- Sources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus.
- Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans.
- Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
- Rowell’s syndrome: a rare but distinct entity in rheumatology.
- StatPearls
- StatPearls
- Dirofilaria immitis in wolves recolonizing northern Italy: are wolves competent hosts?
- Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
- Correction: Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment.
- Images in Vascular Medicine. Marjolin’s ulcer with concurrent systemic lupus and venous disease.
- Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis.
- Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.
- Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
- Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus.
- Invasive maxillary aspergillosis in a patient with systemic lupus erythematosus: Case report.
- Expressions of IFN-γ and IL-4 before and after Treatment of Lupus Nephritis with Traditional Chinese Medicine Combined with Cyclophosphamide and Their Values for Efficacy Prediction and Evaluation.
- Bortezomib at therapeutic doses poorly passes the blood-brain barrier and does not impair cognition.
- Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
- Hepatic Infarction Caused by Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus.
- Renal amyloidosis in a patient with systemic lupus erythematosus.
- Long-Term Outcomes of Renal Transplant in Patients With End-Stage Renal Failure Due to Systemic Lupus Erythematosus and Granulomatosis With Polyangiitis.
- COVID-19 Pandemic – A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
- Facial erythema after the treatment of dupilumab in SLE patient.
- Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.
- Evaluation of the inhibitory effect of tacrolimus combined with mycophenolate mofetil on mesangial cell proliferation based on the cell cycle.
- High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
- Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
- De novo subacute cutaneous lupus erythematosus like eruptions in the setting of PD-1 or PD-L1 inhibitor therapy: clinical-pathological correlation.
- Peripheral blood circular RNA hsa_circ_0082688-hsa_circ_0008675 can be used as a candidate biomarker of systemic lupus erythematosus with renal involvement.
- Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion.
- The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis.
- Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
- Hydroxychloroquine and coronavirus disease 19.
- Cerebral Microhemorrhage and Purpuric Rash in COVID-19: The Case for a Secondary Microangiopathy.
- A novel monoclonal antibody against human B7-1 protects against chronic graft-vs.-host disease in a murine lupus nephritis model.
- PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature.
- Post-procedural Bacillus cereus septic arthritis in a patient with systemic lupus erythematosus.
- Chloroquine to fight COVID-19: A consideration of mechanisms and adverse effects?
- The Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth with Systemic Lupus Erythematosus.
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
- Belimumab as Add-on Therapy in Lupus Nephritis.
- Medical conditions, pregnancy perspectives and contraceptive decision-making among young people: an exploratory, qualitative analysis.
- An objective method of diagnosing hydroxychloroquine maculopathy.
- Extracellular vesicles in Inflammatory Skin Disorders: from Pathophysiology to Treatment.
- Antiphospholipid Antibodies Are Not Associated with Clinical Parameters or Prognostic Outcomes in Patients with Non-Hodgkin’s Lymphoma.
- Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.
- Management of cardiovascular disease in patients with systemic lupus erythematosus.
- Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients.
- Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies.
- Unilateral facial erythematous patch as the presenting sign of systemic lupus erythematosus.
- Genotype-Guided Hydralazine Therapy.
- B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis.
- Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus.
- Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders.
- IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis.
- Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.
- COPA syndrome, 5 years after: where are we?
- Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus.
- Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus.
- [Antiphospholipid syndrome : Update on diagnostics and management].
- Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report.
- Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation.
- Modified Zhibai Dihuang pill, a traditional Chinese medicine formula, on steroid withdrawal in systemic lupus erythematosus: A systematic review and meta-analysis.
- Autoantibody-dependent amplification of inflammation in SLE.
- Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus.
- Efficacy of a sequential treatment by belimumab in monogenic systemic lupus erythematosus.
- Efficacy and safety of sirolimus in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
- New biomarkers in SLE: from bench to bedside.
- The BAFF / APRIL system as therapeutic target in multiple sclerosis.
- Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis.
- Snare salvage technique for deformed WEB device after deployment.
- Pregnancy in systemic lupus erythematosus.
- Immunomodulatory Drugs in the Management of SARS-CoV-2.
- Bilateral simultaneous Central Retinal Artery Occlusion (CRAO) in a patient with Systemic Lupus Erythematosus (SLE).
- Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE).
- Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre.
- Epilepsy in systemic lupus erythematosus.
- Inhibition of IRF5 hyper-activation protects from lupus onset and severity.
- Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-associated cutaneous adverse events.
- How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
- Extracellular vesicles and lupus nephritis – New insights into pathophysiology and clinical implications.
- Infection-related glomerulonephritis mimicking lupus nephritis.
- Incidence, Clinical Features, and Outcomes of Late-onset Neutropenia from Rituximab for Autoimmune Disease.
- Biologic therapies for systemic lupus erythematosus: where are we now?
- Update on antimalarials and systemic lupus erythematosus.
- Sixteenth international congress on antiphospholipid antibodies task force. Report on obstetric antiphospholipid syndrome.
- Catch the rainbow: Prognostic factor of sarcoidosis.
- New insights into the role of antinuclear antibodies in systemic lupus erythematosus.
- Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19.
- The Association Between Oral Health and Skin Disease.
- A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
- Systemic lupus erythematosus presenting as thrombotic thrombocytopaenic purpura in a child: a diagnostic challenge.
- Clinical analysis of 4 cases of Wernekink commissure syndrome.
- Stercoral Perforation of Sigmoid Colon in Systemic Lupus Erythematosus: A Rare Cause of Peritonitis.
- Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis.
- Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis.
- Primary breast diffuse large B-cell lymphoma in a patient with systemic lupus erythematosus: A case report and review of the literature.
- TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases.
- Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature.
- Rituximab in Treatment of Children with Refractory Vasculitis and Systemic Lupus Erythematosus – Single Center Experience in Croatia.
- [Autoimmune hemolytic anemias].
- [Hip osteonecrosis].
- Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases.
- A 31-Year-Old Man with COVID-19-Associated Empyema and Lupus Anticoagulant.
- Complement Properdin Determines Disease Activity in MRL/lpr Mice.
- Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Treatment.
- Steroid treatment promotes an M2 anti-inflammatory macrophage phenotype in childhood lupus nephritis.
- Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment.
- Essential role and therapeutic targeting of the glomerular endothelial glycocalyx in lupus nephritis.
- Establishing Consensus Understanding of the Barriers to Drug Development in Lupus.
- Case report: a 10-year-old girl with primary hypoparathyroidism and systemic lupus erythematosus.
- Increased levels of plasma nucleotides in patients with rheumatoid arthritis.
- Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study.
- Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Mathian et al.
- Comment on ‘Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19’ by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France.
- Pharmacokinetics and pharmacodynamics of cenerimod, a selective S1P1 R modulator, are not affected by ethnicity in healthy Asian and Caucasian subjects.
- Physical activity, sedentary behaviour and their associations with cardiovascular risk in systemic lupus erythematosus.
- Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate.
- The multi-targets mechanism of hydroxychloroquine in the treatment of systemic lupus erythematosus based on network pharmacology.
- Mycophenolic acid area under the concentration-time curve is associated with therapeutic response in childhood-onset lupus nephritis.
- Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview.
- Cast-like calcification in the superior vena cava in a young woman with lupus nephritis on hemodialysis.
- Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice.
- Lupus Nephritis: Breaking the Lull.
- Lupus Nephritis: How Far Have We Come, and Where Are We Headed?
- Lupus Nephritis and Kidney Transplantation: Where Are We Today?
- Bullous lupus as the first manifestation of systemic lupus erythematosus in the pediatric population: A diagnostic challenge in daily practice.
- [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
- An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
- Lupus Vasculitis.
- Tripterygium and its plant extraction for systemic lupus erythematosus: A protocol for systematic review and meta analysis.
- The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
- Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.
- Association of microRNA 17 host gene variant (rs4284505) with susceptibility and severity of systemic lupus erythematosus.
- Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
- Severe systemic lupus erythematosus flare after abatacept treatment.
- Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.
- The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine.
- Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues.
- Hydroxychloroquine is protective to the heart, not Harmful: A systematic review.
- Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case report.
- Systemic Lupus Erythematosus: Targeted literature review of the epidemiology, current treatment and disease burden in the Asia Pacific region.
- COVID-19 versus HIT hypercoagulability.
- Stereochemical Differences in Fluorocyclopropyl Amides Enable Tuning of Btk Inhibition and Off-Target Activity.
- The first case of natalizumab-induced subacute cutaenous lupus erythematosus.
- [Update on treatments and innovations in systemic auto-immune diseases].
- Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
- EBV-positive mucocutaneous ulcer in a patient with systemic lupus erythematosus.
- Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells.
- Refractory lupus panniculitis treated successfully with rituximab: Two cases.
- An Unusual and Rare Case of a Seronegative Male Patient With Lupus Nephritis.
- Cutaneous squamous cell carcinoma as a complication of discoid lupus erythematosus.
- Volunteer based approach to dog vaccination campaigns to eliminate human rabies: Lessons from Laikipia County, Kenya.
- Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
- Anifrolumab, a Monoclonal Antibody to the Type I Interferon Receptor Subunit 1, for the Treatment of Systemic Lupus Erythematosus: An Overview From Clinical Trials.
- Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature.
- Lower CH50 as a predictor for intractable or recurrent lupus enteritis: A retrospective observational study.
- An unusual neurological presentation: systemic lupus erythematosus mimicking central nervous system infection.
- Bio-inspired adhesive porous particles with human MSCs encapsulation for systemic lupus erythematosus treatment.
- Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach.
- Accelerated, severe lupus nephritis benefits from treatment with honokiol by immunoregulation and differentially regulating NF-κB/NLRP3 inflammasome and sirtuin 1/autophagy axis.
- Cytomegalovirus preventive strategies in lupus nephritis and renal vasculitis treated with immunosuppressants.
- Type B insulin resistance syndrome: a systematic review.
- Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change.
- Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
- Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
- Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
- Belimumab, a useful alternative therapy in systemic lupus erythematosus serositis.
- Microarray-based transcriptional profiling of a mouse model of autoimmune hepatitis.
- Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis.
- Orbital myositis in systemic lupus erythematosus: A case report and literature review.
- A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases.
- Recombinant Zoster Vaccine in Stable SLE Patients
- Cervical Cancer Screening in Women with Systemic Lupus Erythematosus.
- Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study.
- [Hydroxychloroquine treatment rarely causes eye damage when used correctly].
- CircZNF609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging miR-615-5p.
- Fertility preservation in women for medical and social reasons: Oocytes vs ovarian tissue.
- Arterial Hypertension in Systemic Lupus Erythematosus: About 40 Cases.
- Macrophage activation syndrome triggered by active systemic lupus erythematosus : Successful treatment by interleukin-1 inhibition (anakinra).
- Treatment of Cutaneous Lupus Erythematosus With 1064-nm Neodymium-Doped Yttrium Aluminum Garnet Laser Verses Topical Corticosteroid Alone.
- Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study.
- Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
- Lupus low disease activity (SLE) in patients treated with belimumab: a single-center real-life experience (2016-2019).
- Cutaneous lupus erythematosus induced by radiotherapy for breast carcinoma.
- Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina.
- Vertical gaze palsy and intraoral numbness in a patient with neuro-psychiatric systemic lupus erythematosus: A case report and literature review.
- Identification of critical genes in gastric cancer to predict prognosis using bioinformatics analysis methods.
- IFN- γ and TNF- α drive a CXCL10 + CCL2 + macrophage phenotype expanded in severe COVID-19 and other diseases with tissue inflammation.
- Serum syndecan-1, hyaluronan and thrombomodulin levels in patients with lupus nephritis.
- Vitamin D status in a monocentric cohort of systemic lupus erythematosus (SLE) patients and correlations with clinical and immunological profile.
- Coronary artery bypass graft surgery in a young female with systemic lupus erythematosus and its operative challenges: A case report.
- Periocular discoid lupus erythematosus: diagnostic challenges of a clinical and histopathological masquerader.
- Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia.
- Progressive multifocal leukoencephalopathy and sarcoidosis under interleukin 7: The price of healing.
- Therapeutic Plasma Exchange Improved Pregnancy-associated Thrombotic Microangiopathy but not the Pregnancy Outcome in Patient with Systemic Lupus Erythematosus.
- A review of advances in the understanding of lupus nephritis pathogenesis as a basis for emerging therapies.
- Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series Review.
- Very Late-Onset Systemic Lupus Erythematosus as Unusual Cause of Reversible Functional and Cognitive Impairments in an Octogenarian Patient.
- Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties.
- Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence, significance for clinical presentation and disease outcome.
- Potential five-mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma.
- Vitiligo-like depigmentation subsequent to subacute cutaneous lupus erythematosus and hydroxychloroquine treatment.
- Effects of BAFF neutralization on atherosclerosis associated with systemic lupus erythematosus.
- Pickles and warfarin interaction: a case-based review.
- Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
- Children with chronic-refractory autoimmune cytopenias: a single center experience.
- MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets.
- Influence of total western diet on docosahexaenoic acid suppression of silica-triggered lupus flaring in NZBWF1 mice.
- Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations.
- Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity.
- Cricoarytenoid joint arthritis: a possible complication of dermatomyositis.
- Clinical Features and Outcomes of Bilateral Atypical Femoral Fractures.
- An evidence based approach to refractory cutaneous lupus erythematosus.
- Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.
- Mechanism of Follicular Helper T Cell Differentiation Regulated by Transcription Factors.
- Risk of systemic lupus erythematosus in patients with endometriosis: A nationwide population-based cohort study.
- [Proximal myopathy and fulminant heart failure in a 57 year-old female patient with lupus erythematosus].
- Tumour necrosis factor inhibitor-induced myositis in a patient with ulcerative colitis.
- Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review.
- Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study.
- Response to: ‘Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis’ by Singer et al.
- Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus.
- [Lupus anticoagulant-hypoprothrombinemia syndrome associated with follicular lymphoma].
- Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway.
- Ureteric implantation into the bowel portion of augmented bladders during kidney transplantation: a review of urological complications and outcomes.
- Activin-A in the regulation of immunity in health and disease.
- Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases.
- Systemic lupus erythematosus: an expert insight into emerging therapy agents in preclinical and early clinical development.
- Cardiovascular System Affection and Its Relation to First-Year Mortality in Patients Initiating Maintenance Hemodialysis.
- Expression Pattern of Telomerase Reverse Transcriptase (hTERT) Variants and Bcl-2 in Peripheral Lymphocytes of Systemic Lupus Erythematosus Patients.
- Prevention of Infection in the Perioperative Setting in Patients with Rheumatic Disease Treated with Immunosuppression.
- Acute severe sensory ganglionopathy in systemic lupus erythematous.
- Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: ‘Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus’ by Chatzidionysiou et al.
- Response to: ‘Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: ‘Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus’ by Chatzidionysiou et al’ by Bettiol et al.
- Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway.
- CALIBRATE: A Phase 2 Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
- NEW INSIGHTS INTO THE PROGRESSION FROM CUTANEOUS LUPUS TO SYSTEMIC LUPUS ERYTHEMATOSUS.
- Outcome of patients with lupus nephritis under long-term immunonephrological care
- ‘The feeling of not being entitled to something’: fertility, pregnancy, and sexuality among women with systemic lupus erythematosus in South Africa.
- Age at diagnosis and health-related quality of life are associated with fatigue in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort.
- Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus.
- Systemic lupus erythematosus with hypothyroidism as the initial clinical manifestation: A case report.
- Urinary biomarkers in lupus nephritis.
- The First Case of an Infant with Familial A20 Haploinsufficiency in Korea.
- Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn’s disease.
- A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics.
- Ruptured Mycotic Aneurysm of the Distal Circulation in a Patient with Mucormycosis Without Direct Skull Base Extension: Case Report.
- Mechanisms of hypertension in autoimmune rheumatic diseases.
- Topic Modeling and User Network Analysis on Twitter during World Lupus Awareness Day.
- Lupus nephritis in a transgender woman on cross-sex hormone therapy: a case for the role of oestrogen in systemic lupus erythematosus.
- The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK.
- Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
- Lupus-associated protein losing enteropathy (LUPLE) complicated by a hypercoagulable state and successfully treated with belimumab.
- Multiple coronary aneurysms and acute myocardial infarction in a female patient with rhupus: case report and literature review.
- Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic.
- Effects of AS2819899, a novel selective PI3Kδ inhibitor, in a NZB/W F1 mouse lupus-like nephritis model.
- Metabolic regulation of pathogenic autoimmunity: therapeutic targeting.
- Neonatal lupus with left bundle branch block and cardiomyopathy: a case report.
- Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus.
- A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus
- Spontaneous Superior Ophthalmic Vein Thrombosis in a Transgender Man with Systemic Lupus Erythematosus.
- [New directions of pharmacotherapy of immune – inflammatory rheumatic diseases].
- Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in B cells.
- Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
- Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
- Kidney outcomes for children with lupus nephritis.
- Causes of hospitalization in Systemic Lupus Erythematosus: a narrative review.
- Statins in COVID-19: is there any foundation?
- MSCs-released TGFβ1 generate CD4+CD25+Foxp3+ in T-reg cells of human SLE PBMC.
- Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis.
- Outcomes of left ventricular assist device implantation in hypercoagulable patients.
- EHR2Vec: Representation Learning of Medical Concepts From Temporal Patterns of Clinical Notes Based on Self-Attention Mechanism.
- Autoimmune conditions and primary central nervous system lymphoma risk among older adults.
- Genome Variation and Precision Medicine in Systemic Lupus Erythematosus.
- Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report.
- Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis.
- Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.
- Dystrophic Calcinosis Cutis in Systemic Lupus Erythematosus.
- Hydroxychloroquine in rheumatic autoimmune disorders and beyond.
- Rheumatic immune-related adverse events induced by immune checkpoint inhibitors.
- Pulmonary embolism complicated the course of anti-N-methyl-D aspartate receptor encephalitis in a pediatric intensive care unit setting: A case report.
- Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients.
- Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: a case report.
- Effectiveness of Bailing capsules in the treatment of lupus nephritis: A meta‑analysis.
- Unexpected macrophage activation syndrome in a healthy young woman: a case report.
- Centrally Acting ACE Inhibition in SLE
- Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort.
- Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.
- Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.
- Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants.
- Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia.
- Syk inhibitor attenuates inflammation in lupus mice from FcgRIIb deficiency but not in pristane induction: the influence of lupus pathogenesis on the therapeutic effect.
- Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa.
- Type I interferon antagonists in clinical development for lupus.
- Anti-DNA antibodies cross-reactive with β2-glycoprotein I induce monocyte tissue factor through the TLR9 pathway.
- Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2/HO-1 pathway.
- DNA Vaccination With Hsp70 Protects Against Systemic Lupus Erythematosus in (NZB × NZW)F1 Mice.
- Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
- Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases Part 2.
- Bilateral patellar tendon rupture on lupus undergoing corticosteroids: a case report.
- Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents.
- A case of severe choroidal detachment in both eyes due to systemic lupus erythematosus.
- Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
- Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells.
- What every nephrologist needs to know about hydroxychloroquine toxicity .
- Comparison of treatment response and serious infection of tacrolimus, tacrolimus with mycophenolate mofetil, in comparison to cyclophosphamide as induction treatment for lupus nephritis .
- Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study.
- Indwelling pleural catheter and successful autopleurodesis of refractory inflammatory lupus effusion.
- Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: A real world single center study.
- PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
- [Atypical hydroxychloroquine maculopathy in an Asian woman with lupus].
- Macrophage activation syndrome in a patient with systemic lupus erythematosus.
- Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
- Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report.
- MicroRNA-30e-5p has an Integrated Role in the Regulation of the Innate Immune Response during Virus Infection and Systemic Lupus Erythematosus.
- Clinical and histological significance of urinary CD11c+ macrophages in lupus nephritis.
- Kidney Biopsy Findings in Patients with COVID-19.
- Secondary Renal Neoplasia Following Chemotherapy or Radiation in Pediatric Patients.
- Treatment of systemic lupus erythematosus.
- Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.
- Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
- Long Noncoding RNAs and Circular RNAs in Autoimmune Diseases.
- Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2.
- Bronchoalveolar lavage fluid analysis and mortality risk in systemic lupus erythematosus patients with pneumonia and respiratory failure.
- Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.
- Acquired Human Papilloma Virus Type 6-Associated Epidermodysplasia Verruciformis in a Patient With Systemic Lupus Erythematosus.
- Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
- A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis.
- Stakeholder-Engaged Derivation of Patient-Informed Value Elements.
- Outcome of biopsy-proven lupus nephritis with low glomerular filtration rate at presentation.
- Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan.
- Response to: ‘Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India’ by Goyal et al.